L-cycloserine, an inhibitor of sphingolipid biosynthesis, inhibits HIV-1 cytopathic effects, replication, and infectivity

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 2, 1996, Pages 137-141

  Mizrachi, Yaffa ^a   Lev, Meir ^b   Harish, Z ^a   Sundaram, S K ^a   Rubinstein, A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

HIV 1; L Cycloserine; Lymphocytes

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; CYCLOSERINE; GALACTOSYLCERAMIDE; SPHINGOLIPID; SULFATIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 0030054349     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199602010-00004     Document Type: Article

References (18)

1. Meyerhans A, Vartanian J-P, Hultgern C, Plikat U, Karasson A, Wang L, Eriksson S, Wain-Hobson S. Restriction and enhancement of human immunodeficiency type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol 1994;68:535-40.
2. Lori F, MaLkh A, Cara A, Sun D, Weinstein JN, Lisziewicz M, Gallo RC. Hydroxyurea as an inhibitor of human immunodeficiency virus type 1 replication. Science 1994;266:801-4.
3. Sundaram SK, Lev M. Inhibition of sphingolipid synthesis by cycloserine in vitro and in vivo. J Neurochem 1984;42:577-81.
4. Sundaram SK, Lev M. Inhibition of cerebroside synthesis in the brains of mice treated with L-cycloserine. J Lipid Res 1985;26:473.
5. Sundaram SK, Lev M. The long term administration of L-cycloserine to mice; specific reduction of brain cerebroside levels. Neurochem Res 1989;14:41-4.
6. Bhat S, Spitalnik SL, Gonzalez-Scarano F, Silberg DH. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci USA 1991;88:7131-4.
7. Steinhart WL, Busch JS, Oettgen JP, Howland JL. Sphingolipid metabolism during infection of human fibroblast by herpes simplex virus type 1. Intervirology 1984;21:70-6.
8. Schroder EW, Merrick JM. Alteration in glycosphingolipid pattern in a line of African green monkey kidney cells infected with herpesvirus. J Virol 1979;32:734-40.
9. Ruhlig MA, Person S. Alterations of neutral glycolipids in cells infected with syncytium producing mutants in herpes simplex virus type 1. J Virol 1977;24:602-8.
10. Matsuda K, Taki T, Hamanaka S, Kasama T, Rkukawa C, Handa S, Yamamoto N. Glycosphingolipid composition of human T-lymphotropic virus type 1 (HTLV-1) and human immunodeficiency virus type 1 (HIV-1)-infected cell lines. Biochem Biophys Acta 1993;1168:123-9.
11. Aloin RC, Jensen CC, Mobley PW, Gordon LM. Rapid composition and fluidity of human immunodeficiency virus. Proc Natl Acad Sci USA 1988;85:900-4.
12. Casreale D, Stevenson M, Sakai K, Volsky DJ. A human T cell line resistant to cytopathic effect of the human immunodeficiency virus (HIV). Virology 1978;156:40-9.
13. Hannun YA, Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 1989;243:500-7.
14. Van Veldhoven PP, Matthews TJ, Bolognesi DP, Bell RM. Changes in bioactive lipids, alkyacylglycerol and ceramide, occur in HIV-infected cells. Biochem Biophys Res Commun 1992;187:209-16.
15. Hakamori S-I, Igarashi Y. Gangliosides and glycosphingolipids as modulators of cell growth, adhesion and transmembrane signaling. Adv Lipid Res 1993;25:147-62.
16. Goldkorn T, Dressler KA, Muindi J, Radin HS, Mendelsonn J, Menaldino D, Liotto D, Kolesnick RN. Ceramide stimulates epidermal growth factor receptor phosphorylation in A-631 human epidermoid carcinoma cells. J Cell Biochem 1991;266:16092-7.
17. Kawaguchi T, Nakakuma H, Kagimoto T, Shitono K, Kidaka M, Iwamori M, Nagai T, Tagatsuki K. Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytes. Biochem Biophys Res Commun 1989;156:1050-9.
18. 1ck. J Immunol 1992;149:2585-91.